Introduction
In 2010, the European Working Group on Sarcopenia in Older People (EWGSOP) and the International Symposium on Sarcopenia in 2011 established a unified definition of sarcopenia, which highlighted that sarcopenia occurs as a result of a gradual decline in muscle mass. At the beginning of 2018, the Working Group met again (EWGSOP2) to summarize the latest research results of clinical and scientific research on sarcopenia in the past 10 years and revise the diagnostic criteria (Cruz-Jentoft et al., 2019). Sarcopenia is characterized by a gradual and generalized loss of the strength and function of skeletal muscles (Bianchi et al., 2016; Cruz-Jentoft et al., 2010). It has be closely associated with diabetes as well as the risk of subsequent falls, fractures, and physical disabilities (Cruz-Jentoft et al., 2010; Daly et al., 2014; Janssen et al., 2004; Kanazawa et al., 2008; Molina et al., 2017). Therefore, the prevention of sarcopenia can help reduce the risk of falls and secondary fractures, thereby improving the overall prognosis of patients with fractures (McKinnon et al., 2017; Paillard, 2017).
The occurrence of fractures is an important risk factor for sarcopenia (Szulc, Feyt & Chapurlat, 2016). Patellar fracture is a common fracture of the lower limb (Luna-Pizarro et al., 2006) and may entail long-term bed rest for patients, which is an important cause of sarcopenia (Changjie, 2014). The patella is an important component of the knee joint, playing an important role in the attachment of the quadriceps muscle to the patellar ligament and thereby maintaining the stability and functioning of the knee joint. About 40% of the patients with patella fracture have a decrease in knee strength and endurance in the first year (Rafael & Archdeacon, 2016). Thus, patients with patella fracture may be prone to sarcopenia. Therefore, we believe that studying patella fracture may be more useful than other types of limb fractures to identify the risk factors of sarcopenia after lower limb fracture.
However, the pathogenesis of sarcopenia is multi-centric involving various factors, including those related to disease (such as health status and work intensity), treatment (such as surgery and rehabilitation programs and other medical-related issues), and patients (such as age, body mass index (BMI), gender, and education level). In addition, ageing and diabetes have also been implicated as important risk factors for sarcopenia (Barzilay et al., 2009; Kalyani, Corriere & Ferrucci, 2014; Kuo et al., 2009). The risk of sarcopenia is reported to be high among patients with diabetes (Kim et al., 2010). Decrease in muscle mass and the resulting abnormal gait and slow walking speed has been reported as the mechanism underlying sarcopenia (Volpato et al., 2012).
Although several variables that affect sarcopenia have been reported, no method has yet been identified for systematic assessment to predict the risk of post-fracture muscle reduction; therefore, it is necessary to develop accurate predictive tools and early individualized interventions to prevent muscle loss. The Asian Working Group for Sarcopenia (AWGS) and EWGSOP2 established effective criteria for the diagnosis of sarcopenia based on the characteristics of the Asian population; these criteria are being widely used to assess the occurrence and risk factors of sarcopenia (Chen et al., 2014). We believe that the AWGS criteria can be used to predict the occurrence of sarcopenia after patellar surgery by establishing an effective nomogram model.
The aim of this study was to develop an effective and simple tool for predicting sarcopenia in patients undergoing post-fracture patellar surgery. Only the data available for period after the patient’s hospitalization for fracture were used to evaluate the risk of sarcopenia in patients with patella fracture in order to study the effects of early prevention of sarcopenia and obtain accurate guidance for clinical work.
Patients and Methods Patients
This study was designed as a retrospective investigation of the prognosis of elderly patients with patella fracture. The study protocol was approved by the ethics committee of the First People’s Hospital affiliated to Shanghai Jiao Tong University Medical School (approval no. 2019SQ059). The study was performed in accordance with the stipulations of the Helsinki declaration. We first identified patients residing in Shanghai, China, who underwent patellar surgery at the Shanghai First People’s Hospital between January 2013 and October 2018. Between February 2019 and June 2019, we conducted a questionnaire-based survey through appointment-based telephonic interview, outpatient services, and community follow-up. Data for all the patients were collected by the same researcher. Written informed consent was sought from all enrolled subjects before participation in the study; all participating patients provided consent. In this study, we included only fracture patients aged ≥55 years, since postoperative sarcopenia after fractures is rare in young patients (Alkahtani, 2017; Frost et al., 2015; Krzyminska-Siemaszko et al., 2019). The laboratory blood test results taken into consideration were those obtained for the preoperative fasting samples of venous blood.
Inclusion criteria and exclusion criteria
The inclusion criteria for the survey were as follows: (1) diagnosis of sarcopenia according to the AWGS criteria, (2) age ≥55 years, (3) availability of complete data for baseline clinical characteristics (age, body mass index, etc.) and follow-ups, (4) patients had been managed with self-care before surgery, (5) basic communication skills.
Patients were excluded from the study if they had major illnesses, serum creatinine levels of >2.5 mg/dL, liver enzyme levels elevated to more than twice the upper limit of the normal within 6 months prior to the start of the study, unexplained fever or infection, acute heart failure, or organ failure such as renal failure. Patients were also excluded if they did not cooperate with the completion of the basic diagnostic tests. Patients who developed life-threatening conditions during follow-up or conditions that could interfere with the interpretation of the study results were also excluded.
All patients were screened, of which 137 were found to be eligible according to the inclusion criteria and availability of the completed questionnaire. The patients included in the final analysis included 52 males (age: 55–88 years, mean age: 66.1 ± 9.2 years) and 85 females (age: 55–88 years, average age: 65.4 ± 8.1 years). These 137 patients were included in the final analysis.
Methods of assessment
The diagnostic criteria established by the 2014 Asian Working Group for Sarcopenia (AWGS) and EWGSOP2 defines sarcopenia by a walking speed of ≤0.8 m/s and measuring muscle mass (BIA) of ≤7.0 kg/m2 for males and ≤6.0 kg/m2 for females (Cruz-Jentoft et al., 2019; Chen et al., 2014). The pace of decline in walking speed is closely related to the prognosis of patients (Stone et al., 2015; Kutner et al., 2014). Hence, we used a fixed distance of 6 m, as recommended by AWGS, to measure the subject’s daily walking speed. For patients with a walking speed of ≤0.8 m/s, we used the bioelectrical impedance analysis (BIA) to assess muscle mass. The results of BIA are very similar to those of double-energy X-ray absorptiometry and magnetic resonance imaging; BIA also offers the advantages of safety, technical simplicity, low cost, and high patient compliance (Wang et al., 2016; Chien, Huang & Wu, 2008). All the results of BIA have been standardized by using cross-validated Sergi. Muscle mass and BMI of the extremities were measured by using a bioimpedance meter (TANITA RD-953, Japan).
Medical history and basic data collection
The questionnaire contained questions pertaining to various domains, including history of hypertension, diabetes, osteoporosis, malignant tumors, myocardial infarction, and falls as well as educational level, income, and duration of exercise. With regard to smoking habit, patients were classified as current smokers and non-smokers. Alcohol intake was calculated according to the average weekly alcohol consumption. The cut-off for exercise duration was 2 h/week, with duration of <2 h/week being considered as reduced duration. All patients had medical insurance that is provided for Shanghai residents. Additionally, we also reviewed the patients’ medical history and collected their laboratory blood test results.
Statistical analysis
The study cohort was randomized into the training and validation (7:3) groups, which were used for diagnostic and prognostic analysis and to identify and evaluate the model. Statistical analysis was performed using R software (version 3.5.3). All the pre-determined factors described above were included in the LASSO analysis and to reduce the dimensionality of the data, and the best predictors were identified (odds ratio of the OR values of these characteristic factors have 95% confidence intervals and P values <0.05) (Friedman, Hastie & Tibshirani, 2010; Kidd et al., 2018; Sauerbrei, Royston & Binder, 2007). These features were then further filtered using the Support Vector Machine-Recursive Feature Elimination (SVM-RFE) algorithm. Subsequently, the multivariate logistic model was used to analyze the factors identified with the LASSO regression model and Support Vector Machine (SVM) algorithm to establish a prediction model (Kidd et al., 2018). The collected patient data can be used to generate a predictive model that accounts for all the best predictors of sarcopenia, which can be used for the prognostic evaluation of patients with patellar fractures (Iasonos et al., 2008; Balachandran et al., 2015). Next, we plotted the calibration curve to assess the accuracy of the nomogram. However, simple evaluation with the calibration curve would be incomplete (Kramer & Zimmerman, 2007). In addition, we also calculated the C-index and plotted the area under curve (AUC) curve to quantify the predictive power of the nomogram. We then performed further iterations (10,000 resampling) on the nomogram using the R language package for a more accurate measurement of C-index (Pencina & D’Agostino, 2004). Finally, we used the decision curve model to determine the net rate of return in order to test the clinical utility of the nomogram (Vickers et al., 2008). By quantifying the net benefit of different threshold probabilities in patient information, decision curve analysis is used to assess the clinical utility of nomograms (Huang et al., 2016; Van Calster et al., 2018).
Results Basic characteristics of the data
We obtained the completed questionnaires from 137 patients (52 males, 85 females; mean age 65.7 years) with patellar fractures. Patients were classified as those with (45 patients) or without sarcopenia (92 patients), as according to the diagnostic criteria established by the AWGS and EWGSOP2. Details of the patient characteristics are provided in Table 1.
Screening of predictors
We used the LASSO regression model and SVM algorithm (Figs. 1A–1C) to decrease the factors in this study from 28 to 8 major parameters, which were age, BMI, diabetes, postoperative rehabilitation, frequency of outdoor exercise, surgical method used, presence or absence of open fracture, and removal of internal fixation.
Construction of a personalized prediction model
Using the eight abovementioned predictors identified with the logistic model analysis, we used the RMS package of R software to construct the column diagram, as shown in Figs. 2A (see 2B for details).
Evaluation the nomogram
The calibration curve of the nomogram showed good agreement (Fig. 3A), which suggested that this model could be used to predict the risk of sarcopenia in patients after patellar fracture. In addition, the AUC of this prediction model was 0.884058 (receiver operating curve shown in Fig. 3B). Further, the model showed a good prediction rate (C-index: 0.88; 95% CI [0.80552–0.95448]) and good correction effect. The C index was 0.97 for the validation queue and 0.894 for the entire cohort. This proved that this model was very efficient in terms of predictive power.
Clinical application
The decision curve analysis of the nodule prediction model for postoperative sarcopenia in cases of patellar fractures is shown in Fig. 3C. This implies that the current prediction model can better guide clinical practice and facilitate early planning and implementation of clinical intervention to reduce the risk of sarcopenia, thus reducing the overall risk of muscle loss in the population.
| Characteristics | |||
|---|---|---|---|
| Sarcopenia (n = 45) | Normal (n = 92) | Total (n = 137) | |
| Gender | |||
| Female | 29(64.4%) | 56(60.9%) | 85 (62.0%) |
| Male | 16(35.6%) | 36(39.1%) | 52 (38.0%) |
| Age | |||
| Mean (SD) | 69.3(9.7) | 63.9(7.3) | 65.7 (7.8) |
| Median [MIN, MAX] | 67 [55,88] | 62[55,90] | 63[55,89] |
| Education_level | |||
| Primary (0–6 years) | 10(22.2%) | 16(17.4%) | 26(19.0%) |
| Secondary (7–12 years) | 24(53.3%) | 49(53.3%) | 73(53.3%) |
| Higher (>12 years) | 11(24.4%) | 27(29.3%) | 38(27.7%) |
| BMI | |||
| Mean (SD) | 22.1(2.8) | 24.7(3.2) | 23.9(3.5) |
| Median [MIN, MAX] | 22.8[17.5,26.8] | 25[17.4,31.8] | 24.2[17.4,31.8] |
| Drinking | |||
| Yes | 9(20.0%) | 38(41.3%) | 90(65.7%) |
| No | 36(80.0%) | 54(58.7%) | 47(34.3%) |
| Smoking | |||
| Yes | 15(33.3%) | 23(25.0%) | 99(72.3%) |
| No | 30(66.7%) | 69(75.0%) | 38(27.7%) |
| Exercise | |||
| >2 h/week | 24(53.3%) | 75(81.5%) | 99(72.3%) |
| ≤2 h/week | 21(46.7%) | 17(18.5%) | 38(27.7%) |
| Surgical technique | |||
| Cannulated screws+Standard tension band | 39(86.7%) | 84(91.3%) | 123(89.8%) |
| Standard tension band | 4(8.9%) | 7(7.6%) | 11(8.0%) |
| Plaster fixation | 2(4.4%) | 1(1.0%) | 3(2.2%) |
| Rehabilitation training | |||
| Yes | 13(28.9%) | 47(51.1%) | 60(43.8%) |
| No | 32(72.1%) | 45(48.9%) | 77(56.2%) |
| Internal fixation removal | |||
| Yes | 13(28.9%) | 37(40.2%) | 50(36.5%) |
| No | 32(72.1%) | 55(60.8%) | 87(63.5%) |
| Diabetes | |||
| Yes | 23(51.1%) | 24(26.1%) | 47(34.3%) |
| No | 22(48.9%) | 68(73.9%) | 90(65.7%) |
| High blood pressure | |||
| Yes | 15(33.3%) | 22(23.9%) | 37(27.0%) |
| No | 30(66.7%) | 70(76.1%) | 100(73.0%) |
| Hyperlipidemia | |||
| Yes | 12(26.7%) | 25(27.2%) | 37(27.0%) |
| No | 33(73.3%) | 67(72.8%) | 100(73.0%) |
| History of stroke or myocardial infarction | |||
| Yes | 4(8.9%) | 3(3.3%) | 7(5.1%) |
| No | 41(91.1%) | 89(96.7%) | 130(94.9%) |
| Heart disease | |||
| Yes | 6(13.3%) | 8(8.7%) | 123(89.8%) |
| No | 39(86.7%) | 84(91.3%) | 14(10.2%) |
| Renal insufficiency | |||
| Yes | 1 (2.2%) | 0(0.0%) | 1(0.7%) |
| No | 44 (97.8%) | 92(100.0%) | 136(99.3%) |
| History of cancer | |||
| Yes | 1 (2.2%) | 2(2.2%) | 3(2.2%) |
| No | 44 (97.8%) | 90(97.8%) | 134(97.8%) |
| Asthma | |||
| Yes | 2(4.4%) | 3(3.3%) | 5(3.6%) |
| No | 43(95.6%) | 89(96.7%) | 132(96.4%) |
| Blood type | |||
| A | 12(26.7%) | 31(33.7%) | 43(31.4%) |
| B | 4(8.9%) | 29(31.5%) | 33(24.1%) |
| AB | 15(33.3%) | 8(8.7%) | 23(16.8%) |
| O | 14(31.1%) | 24(26.1%) | 38(27.7%) |
| Perioperative blood transfusion | |||
| Yes | 0(0.0%) | 0(0.0%) | 0(0.0%) |
| No | 45(100.0%) | 92(100.0%) | 137(100.0%) |
| Follow-up time(year) | |||
| Mean (SD) | 3.7(1.6) | 3.7(1.7) | 3.7(1.7) |
| Median [MIN, MAX] | 3.6[0.83,6.25] | 3.46[8.3,6.25] | 3.7[0.83,6.25] |
| Length_of_hospital_stay | |||
| Mean (SD) | 10.7(5.1) | 10.3(4.5) | 10.4(4.8) |
| Median [MIN, MAX] | 10[3,24] | 10[3,26] | 10[3,26] |
| Treatment group | |||
| Group A | 19(42.2%) | 42(45.7%) | 61(44.5%) |
| Group B | 26(57.8%) | 50(54.3%) | 76(55.4%) |
| Bone nonunion | |||
| Yes | 2(4.4%) | 1(1.0%) | 3(2.2%) |
| No | 43(95.6%) | 91(98.9%) | 134(97.8%) |
| Open fracture | |||
| Yes | 5(11.1%) | 3(3.3%) | 8(5.8%) |
| No | 40(88.9%) | 89(96.7%) | 129(94.1%) |
| Multiple fracture | |||
| Yes | 2(4.4%) | 4(4.3%) | 6(4.3%) |
| No | 43(95.6%) | 88(95.7%) | 131(95.6%) |
| Infection | |||
| Yes | 4(8.9%) | 3(3.3%) | 7(5.1%) |
| No | 41(91.1%) | 89(96.7%) | 130(94.9%) |
| Classification of fracture | |||
| Upper or lower pole | 17(37.8%) | 32(34.8%) | 49(35.8%) |
| Comminuted fracture | 11(24.4%) | 13(14.1%) | 24(17.5%) |
| Transverse | 15(33.3%) | 38(41.3%) | 53(38.7%) |
| Undisplaced | 0(0.0%) | 5 (5.4% ) | 5(3.6%) |
| Vertical fracture | 2(4.4%) | 4(4.3%) | 6(4.3%) |
DOI: 10.7717/peerj.8793/table-1
Discussion
With the development and availability of R software, the nomogram prediction model is now being widely used in prognostic evaluation and assessment of treatment efficacy (Wang et al., 2019; Polterauer et al., 2012; Zhu et al., 2013). Additionally, the nomogram prediction model has well-defined quantitative indicators, which facilities accurate evaluation of treatment outcome and prognosis (Wei et al., 2017). In this paper, we describe, for the first time, the use of a nomogram model for the assessment of the risk of post-fracture sarcopenia.
In this study, we developed and validated a new tool for predicting postoperative sarcopenia in patients with patellar fractures by using only eight easily available variables. Our preliminary tests reveal that this model can serve as a relatively accurate predictor of whether or not muscle loss occurs in patients who undergo surgery for patellar fractures. Internal sampling showed that the model has strong predictive ability, while high values of C-index and AUC suggest that this model can be widely used for the prediction of postoperative sarcopenia in patients, with good accuracy (Wei et al., 2017).
In our study population, 31% of the patients developed sarcopenia. Analysis of the risk factors for sarcopenia included the following factors: age, BMI, diabetes, postoperative rehabilitation, frequency of outdoor exercise, surgical method used, presence or absence of open fractures, and removal of internal fixation. Our predictive model showed that low BMI, diabetes, lack of rehabilitation after surgery, lack of regular exercise and different surgical methods may be the key individual factors that lead to postoperative muscle loss.
Enlarge this image.Figure 1: Demographic and clinical feature selection using the LASSO binary logistic regression model and support vector machine algorithm. (A) In the Lasso model, the choice of the optimal parameters used a five-fold cross-validation approach. Using the partial likelihood anomaly curve and the log (lambda) plot, the vertical line is drawn at the optimal value to obtain the included feature factors. (B) The lambda curve generates a profile based on the log (lambda) sequence. Vertical lines were drawn at the values selected by the five-fold cross-validation method, and 16 characteristic factors were selected. (C) Using the support vector machine SVM-RFE algorithm to further screen these 16 characteristic factors, we finally established a prediction model with eight best features with an average 10-fold cross-validation score of 0.8531. DOI: 10.7717/peerj.8793/fig-1
Enlarge this image.Figure 2: Nomogram model and prediction factors for sarcopenia in elderly patients with patellar fracture. (A) Nomogram model to predict the risk of sarcopenia after patella fracture. Note: eight factors including age, BMI, diabetes, postoperative rehabilitation, frequency of outdoor exercise, surgical method used, presence or absence of open fracture, and removal of internal fixation were included. (B) The forest chart of prediction factors for sarcopenia in elderly patients with patellar fracture. DOI: 10.7717/peerj.8793/fig-2
Enlarge this image.Figure 3: Evaluation of the nomogram prediction model. (A) A calibration curve for the predictive model of sarcopenia in cases of patella fracture. Note: The x-axis is the risk of sarcopenia. The y-axis represents the actual incidence of sarcopenia. The diagonal dashed line represents a perfect prediction of an ideal model. The solid line indicates the predictive power of this predictive model, and the more it fits with the dotted line, the better the predictive ability. (B) The area under the curve (AUC) of the sarcopenia prediction model indicates the probability of accurately predicting whether or not the patient has sarcopenia in a randomly selected case. The model exhibited good predictive power, and the AUC values of the training group (red), the test group (green), and the whole sample (blue) are 0.8917397, 0.9476584, and 0.9114173, respectively. (C) The decision curve of the nomogram. The figure shows the decision analysis curves for training, test, and overall groups. DOI: 10.7717/peerj.8793/fig-3
As shown in several other studies, a decrease in BMI is often indicative of a decrease in the muscle strength of the limbs (Perna et al., 2015; Rondanelli et al., 2017), and patients with sarcopenia generally have relative low BMI (Perez-Sousa et al., 2019). Therefore, a decline in BMI is an important manifestation of sarcopenia in patients undergoing surgery after fracture. In addition, studies have also shown that very low weight is closely related to the occurrence of sarcopenia (Yu et al., 2014). For the elderly, while obese body types can induce and worsen many diseases, low body weight is also associated with poor health and is an important risk factor for death (Goh & Tong, 2010). High BMI can be considered as protective against the development of sarcopenia in the elderly (Yu et al., 2014). Therefore, maintaining a high BMI through intake of adequate nutrients can prevent the occurrence of postoperative sarcopenia in elderly fracture patients (Veronese et al., 2019).
More than 422 million people worldwide have been estimated to have diabetes (Cameron et al., 2008), and sarcopenia has been reported as a complication of diabetes (Kalyani et al., 2015; Trierweiler et al., 2018), Our study confirmed that diabetes was an important risk factor for muscle reduction in patients with patellar fractures. The incidence of sarcopenia has also been reported to be significantly high in patients with poor glycemic control, and sarcopenia in turn leads to the worsening of diabetes (Park et al., 2006). This is because in the presence of type 2 diabetes, insulin resistance results in autophagy, degradation of muscle protein (ubiquitin–proteasome proteolytic pathway), and mitochondrial dysfunction; these processes eventually lead to the loss of muscle mass and muscle strength. Muscle mass and loss of muscle strength, in turn, lead to a potential increase in insulin resistance; additionally, further progression of mitochondrial dysfunction can aggravate insulin resistance, ultimately compromising diabetes control and then stimulating pathways leading to further muscle loss (Fujita et al., 2009; Jerusalem, Engel & Peterson, 1975; Kalyani et al., 2012; Kaushik, Singh & Cuervo, 2010; Kelley et al., 2002; Mogensen et al., 2007; Phielix & Mensink, 2008; Wang et al., 2006). This vicious circle between muscle reduction and diabetes can be broken by rehabilitation exercise, which is known to have a beneficial effect on bone metabolism (Gao et al., 2016). Further, studies have shown that aerobic exercise with appropriate resistance training is an economic and effective intervention and that it is helpful for effectively controlling diabetes and improving the condition of elderly diabetic patients (Tan, Li & Wang, 2012). These findings are consistent with the results of our study, where our predictive model demonstrated that postoperative rehabilitation exercise and regular physical exercise can prevent the development of sarcopenia (Conceição & Ugrinowitsch, 2019).
The maximum load that the quadriceps can bear can reach 3200N, and the sputum can reach 2800N. In healthy young people, the load on the knee joint can reach 6000N or above (Huberti et al., 1984). This value refers to the load requirement to be achieved after surgery; strong and stable internal fixation is particularly important for postoperative rehabilitation of patellar fractures. The usage of cannulated screws with standard tension band can often help achieve stable internal fixation (Rafael & Archdeacon, 2016). In addition, conservative treatment (such as plaster splint) can be used for fractures with partial knee extension devices intact while long-term immobilization can lead to the development and deterioration of sarcopenia (Cohen, Nathan & Goldberg, 2015).
Interestingly, we found that implant removal is a predictor of functional recovery of the knee joint after surgery. Retention of internal fixation has many risks, including screw fracture, postoperative fracture, important tissue damage, major bleeding, intraoperative fracture, infection, poor wound healing, etc (Arora et al., 2007). However, with thorough preoperative preparation, these complications were avoided in our patients. Additionally, some patients may develop limited joint mobility due to the retention of internal fixation. Retention of internal fixation also hinders the removal of heterotopic bone and soft tissue release, so it must be taken out for complete release of the tissues (Park et al., 2010; Ring & Jupiter, 2004; Wang et al., 2014).
Our prediction model also highlights age as an important risk factors for the development of sarcopenia. Baumgartner et al. (1998) have shown that the incidence of sarcopenia in patients aged between 65 and 70 years ranges at 13–24%. Further, studies have also shown that sarcopenia may occur in as many as half of elderly subjects aged ≥80 years (Volpato et al., 2014; Von Haehling, Morley & Anker, 2010). The study also suggests that open fractures may be a poor prognostic factor for fracture patients; this is consistent with the findings of previous studies that have shown that open fractures led to more complications and prolonged hospitalization (Rees et al., 2019). Moreover, studies have also shown that prolonged hospitalization affects patients’ daily activities (Wanigatunga et al., 2019).
The predictive tool developed by us offers several benefits: (1) Using a predictive tool for postoperative muscle reduction in patients with patellar fractures enables individualized risk prediction, which can indirectly improve the overall patient outcomes (Kardas, Lewek & Matyjaszczyk, 2013). (2) Our model can serve as an effective sarcopenia risk prediction tool, which would enable clinicians to identify patients at a high risk of developing sarcopenia and take appropriate measures to prevent the same. (3) Further, our assessment tool can provide a theoretical background to guide further clinical research on sarcopenia. For example, our nomogram prediction model can be used to facilitate the selection of patients with high risk of sarcopenia in clinical trials. (4) Furthermore, simple early interventions, such as the engagement of medical reminders and family support, will help reduce the risk of postoperative sarcopenia in high-risk patients (Martone et al., 2017). In summary, patients undergoing post-fracture surgery should be recommended treatment for diabetes, post-operative rehabilitation, regular physical activity, and education regarding postoperative management in order to reduce the risk of sarcopenia (Abdelhafiz & Sinclair, 2015).
Therefore, an accurate prognostic assessment tool would enable physicians to evaluate the risk of sarcopenia in a timely manner and accordingly make necessary interventions to improve the prognosis of patients, while also eliminating the wasteful use of medical resources caused by false-positive results. Although it is difficult to completely eliminate the occurrence of sarcopenia, it may be certainly possible to reduce its risk through reasonable evaluation and cost-effective interventions. This would substantially improve the outcomes in patients undergoing post-fracture surgery and therefore our findings have important clinical significance.
Our current study also has a few limitations. First, our sample population contains fewer males than females due to the higher risk of fractures in the latter (Johansson, Nordstrom & Nordstrom, 2016). Thus, this cohort is not representative of all patients with patellar fractures. Second, for the risk factor analysis in this study, we did not include all the risk factors for muscle reduction after patellar fractures. Third, although our prediction model has good internal sampling, the inclusion of stable external data is still necessary for further validation. Fourth, the data used in this study were collected from the patients’ clinical history and long-term follow-up data; although we take all measures to ensure accuracy of the data as much as possible, because of the high patient number, it may not be entirely possible to rule out missing or incorrect information. Fifth, because of the limited sample size, surgical methods are limited.
In this paper, we described a new predictive model that helps clinicians assess the risk of sarcopenia with good accuracy, in elderly patients with patellar fractures. Our findings indicated that the most common risk factors for muscle reduction in patients after fractures include advanced age, low BMI, diabetes, and open fracture. On the other hand, postoperative rehabilitation training, regular outdoor exercise, removal of internal fixation, and strong internal fixation technique were identified as factors protecting against muscle loss. We believe that after further validation through statistical testing and trials on random population samples, this model can be economically and effectively used for predicting the of postoperative muscle reduction in elderly patients with patellar fractures. Accurate estimation of individual risks can help clinicians and patients adopt appropriate modifications in lifestyle and medical interventions. Further research is warranted to determine whether change in interventions based on this nomogram prediction model can effectively reduce the risk of sarcopenia and improve patient outcomes.
Additional Information and Declarations
Competing Interests
The authors declare there are no competing interests.
Author Contributions
Yi-sheng Chen conceived and designed the experiments, performed the experiments, analyzed the data, prepared figures and/or tables, authored or reviewed drafts of the paper, and approved the final draft.
Yan-xian Cai conceived and designed the experiments, performed the experiments, analyzed the data, authored or reviewed drafts of the paper, and approved the final draft.
Xue-ran Kang conceived and designed the experiments, performed the experiments, prepared figures and/or tables, and approved the final draft.
Zi-hui Zhou conceived and designed the experiments, performed the experiments, prepared figures and/or tables, authored or reviewed drafts of the paper, and approved the final draft.
Xin Qi conceived and designed the experiments, analyzed the data, authored or reviewed drafts of the paper, and approved the final draft.
Chen-ting Ying conceived and designed the experiments, analyzed the data, prepared figures and/or tables, and approved the final draft.
Yun-peng Zhang conceived and designed the experiments, analyzed the data, prepared figures and/or tables, authored or reviewed drafts of the paper, and approved the final draft.
Jie Tao conceived and designed the experiments, authored or reviewed drafts of the paper, and approved the final draft.
Human Ethics
The following information was supplied relating to ethical approvals (i.e., approving body and any reference numbers):
This study was approved by the Institutional Ethics Review Board of Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China (2019SQ059).
Data Availability
The following information was supplied regarding data availability:
Raw data is available as a Supplementary File.
Funding
This work was supported by the National Natural Science Foundation of China grants (81371963) and the Project of Shanghai Jiaotong University (601N16025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Abdelhafiz AH, Sinclair AJ. 2015. Diabetes, nutrition, and exercise. Clinics in Geriatric Medicine 31(3):439-451
Alkahtani SA. 2017. A cross-sectional study on sarcopenia using different methods: reference values for healthy Saudi young men. BMC Musculoskeletal Disorders 18(1):119
Arora R, Lutz M, Hennerbichler A, Krappinger D, Espen D, Gabl M. 2007. Complications following internal fixation of unstable distal radius fracture with a palmar locking-plate. Journal of Orthopaedic Trauma 21(5):316-322
Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. 2015. Nomograms in oncology: more than meets the eye. The Lancet. Oncology 16(4):e173-e80
Barzilay JI, Cotsonis GA, Walston J, Schwartz AV, Satterfield S, Miljkovic I, Harris TB, Health ABC Study. 2009. Insulin resistance is associated with decreased quadriceps muscle strength in nondiabetic adults aged >or=70 years. Diabetes Care 32(4):736-738
Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, Garry PJ, Lindeman RD. 1998. Epidemiology of sarcopenia among the elderly in New Mexico. American Journal of Epidemiology 147(8):755-763
Bianchi L, Ferrucci L, Cherubini A, Maggio M, Bandinelli S, Savino E, Brombo G, Zuliani G, Guralnik JM, Landi F, Volpato S+1 more. 2016. The predictive value of the EWGSOP definition of Sarcopenia: results from the InCHIANTI study. The Journals of Gerontology Series A, Biological Sciences and Medical Sciences 71(2):259-264
Cameron A, Magliano D, Zimmet P, Welborn T, Colagiuri S, Tonkin A, Shaw JE. 2008. The metabolic syndrome as a tool for predicting future diabetes: the AusDiab study. Journal of Internal Medicine 264(2):177-186
Changjie Z. 2014. The common bone and joint injury rehabilitation for the elderly. Chinese Journal of Geriatrics 33(7):711-713
Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS, Chou MY, Chen LY, Hsu PS, Krairit O, Lee JS, Lee WJ, Lee Y, Liang CK, Limpawattana P, Lin CS, Peng LN, Satake S, Suzuki T, Won CW, Wu CH, Wu SN, Zhang T, Zeng P, Akishita M, Arai H+16 more. 2014. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. Journal of the American Medical Directors Association. 15:95-101
Chien MY, Huang TY, Wu YT. 2008. Prevalence of sarcopenia estimated using a bioelectrical impedance analysis prediction equation in community-dwelling elderly people in Taiwan. Journal of the American Geriatrics 56(9):1710-1715
Cohen S, Nathan JA, Goldberg AL. 2015. Muscle wasting in disease: molecular mechanisms and promising therapies. Nature Reviews Drug Discovery 14(1):58-74
Conceição MS, Ugrinowitsch C. 2019. Exercise with blood flow restriction: an effective alternative for the non-pharmaceutical treatment for muscle wasting. J Cachexia Sarcopenia Muscle 10(2):257-262
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Roll Y, Schneider SM, Topinková E, Vandewoude M+2 more. 2010. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in older people. Age and Ageing 39(4):412-423
Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, Cooper C, Landi F, Roll Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M, Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), the Extended Group for EWGSOP2+8 more. 2019. Sarcopenia: revised European consensus on definition and diagnosis. Age and Ageing 48(1):16-31
Daly RM, O’Connell SL, Mundell NL, Grimes CA, Dunstan DW, Nowson CA. 2014. Protein-enriched diet, with the use of lean red meat, combined with progressive resistance training enhances lean tissue mass and muscle strength and reduces circulating IL-6 concentrations in elderly women: a cluster randomized controlled trial. The American Journal of Clinical Nutrition 99(4):899-910
Friedman J, Hastie T, Tibshirani R. 2010. Regularization paths for generalized linear models via coordinate descent. Journal of Statistical Software 33(1):1-22
Frost M, Nielsen TL, Brixen K, Andersen M. 2015. Peak muscle mass in young men and sarcopenia in the ageing male. Osteoporosis International 26(2):749-756
Fujita S, Glynn EL, Timmerman KL, Rasmussen BB, Volpi E. 2009. Supraphysiological hyperinsulinaemia is necessary to stimulate skeletal muscle protein anabolism in older adults: evidence of a true age-related insulin resistance of muscle protein metabolism. Diabetologia 52(9):1889-1898
Gao S, Cheng Y, Zhao L, Chen Y, Liu Y. 2016. The relationships of irisin with bone mineral density and body composition in PCOS patients. Diabetes/Metabolism Research and Reviews 32(4):421-428
Goh VH-H, Tong TY. 2010. Association of age and physical exercise with bodyweight and body composition in Asian Chinese men. The Aging Male 13(4):265-274
Huang YQ, Liang CH, He L, Tian J, Liang CS, Chen X, Ma ZL, Liu ZY. 2016. Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. Journal of Clinical Oncology 34(18):2157-2164
Huberti HH, Hayes WC, Stone JL, Shybut GT. 1984. Force ratios in the quadriceps tendon and ligamentum patellae. Journal of Orthopaedic Research 2(1):49-54
Iasonos A, Schrag D, Raj GV, Panageas KS. 2008. How to build and interpret a nomogram for cancer prognosis. Journal of Clinical Oncology 26(8):1364-1370
Janssen I, Baumgartner RN, Ross R, Rosenberg IH, Roubenoff R. 2004. Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. American Journal of Epidemiology 159(4):413-421
Jerusalem F, Engel AG, Peterson HA. 1975. Human muscle fiber fine structure: morphometric data on controls. Neurology 25(2):127-134
Johansson J, Nordstrom A, Nordstrom P. 2016. Greater fall risk in elderly women than in men is associated with increased gait variability during multitasking. Journal of the American Medical Directors Association 17(6):535-540
Kalyani RR, Corriere M, Ferrucci L. 2014. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. The Lancet Diabetes & Endocrinology 2(10):819-829
Kalyani RR, Metter EJ, Egan J, Golden SH, Ferrucci L. 2015. Hyperglycemia predicts persistently lower muscle strength with aging. Diabetes Care 38(1):82-90
Kalyani RR, Tian J, Xue QL, Walston J, Cappola AR, Fried LP, Brancati FL, Blaum CS. 2012. Hyperglycemia and incidence of frailty and lower extremity mobility limitations in older women. Journal of the American Geriatrics Society 60(9):1701-1707
Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Yano S, Sugimoto T. 2008. Combination of obesity with hyperglycemia is a risk factor for the presence of vertebral fractures in type 2 diabetic men. Calcified Tissue International 83(5):324-331
Kardas P, Lewek P, Matyjaszczyk M. 2013. Determinants of patient adherence: a review of systematic reviews. Frontiers in Pharmacology 4(91):1-16
Kaushik S, Singh R, Cuervo AM. 2010. Autophagic pathways and metabolic stress. Diabetes, Obesity & Metabolism 12(Suppl 2):4-14
Kelley DE, He J, Menshikova EV, Ritov VB. 2002. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51(10):2944-2950
Kidd AC, McGettrick M, Tsim S, Halligan DL, Bylesjo M, Blyth KG. 2018. Survival prediction in mesothelioma using a scalable Lasso regression model: instructions for use and initial performance using clinical predictors. BMJ Open Respiratory Research 5(1):e000240
Kim TN, Park MS, Yang SJ, Yoo HJ, Kang HJ, Song W, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM+2 more. 2010. Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS) Diabetes Care 33(7):1497-1499
Kramer AA, Zimmerman JE. 2007. Assessing the calibration of mortality benchmarks in critical care: the Hosmer-Lemeshow test revisited. Critical Care Medicine 35(9):2052-2056
Krzyminska-Siemaszko R, Fryzowicz A, Czepulis N, Kaluzniak-Szymanowska A, Dworak LB, Wieczorowska-Tobis K. 2019. The impact of the age range of young healthy reference population on the cut-off points for low muscle mass necessary for the diagnosis of sarcopenia. European Review for Medical and Pharmacological Sciences 23(10):4321-4332
Kuo CK, Lin LY, Yu YH, Wu KH, Kuo HK. 2009. Inverse association between insulin resistance and gait speed in nondiabetic older men: results from the U.S. National Health and Nutrition Examination Survey (NHANES) 1999–2002. BMC Geriatrics 9:49
Kutner NG, Zhang R, Huang Y, Wasse H. 2014. Gait speed and hospitalization among ambulatory hemodialysis patients: USRDS special study data. World Journal of Nephrology 3(3):101-106
Luna-Pizarro D, Amato D, Arellano F, Hernández A, Joot López-Rojas PJ. 2006. Comparison of a technique using a new percutaneous osteosynthesis device with conventional open surgery for displaced patella fractures in a randomized controlled trial. 20(8):529–535
Martone AM, Marzetti E, Calvani R, Picca A, Tosato M, Santoro L, Di Giorgio A, Nesci A, Sisto A, Santoliquido A, Landi F+1 more. 2017. Exercise and protein intake: a synergistic approach against sarcopenia. BioMed Research International 2017 Article 2672435
McKinnon NB, Connelly DM, Rice CL, Hunter SW, Doherty TJ. 2017. Neuromuscular contributions to the age-related reduction in muscle power: mechanisms and potential role of high velocity power training. Ageing Research Reviews 35:147-154
Mogensen M, Sahlin K, Fernstrom M, Glintborg D, Vind BF, Beck-Nielsen H, Højlund K. 2007. Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes 56(6):1592-1599
Molina P, Carrero JJ, Bover J, Chauveau P, Mazzaferro S, Torres PU. 2017. Vitamin D, a modulator of musculoskeletal health in chronic kidney disease. Journal of Cachexia, Sarcopenia and Muscle 8(5):686-701
Paillard T. 2017. Relationship between muscle function, muscle typology and postural performance according to different postural conditions in young and older adults. Frontiers in Physiology 8 Article 585
Park MJ, Chang MJ, Lee YB, Kang HJ. 2010. Surgical release for posttraumatic loss of elbow flexion. The Journal of Bone and Joint Surgery American Volume 92(16):2692-2699
Park SW, Goodpaster BH, Strotmeyer ES, De Rekeneire N, Harris TB, Schwartz AV, Tylavsky FA, Newman AB. 2006. Decreased muscle strength and quality in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes 55(6):1813-1818
Pencina MJ, D’Agostino RB. 2004. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Statistics in Medicine 23(13):2109-2123
Perez-Sousa MA, Venegas-Sanabria LC, Chavarro-Carvajal DA, Cano-Gutierrez CA, Izquierdo M, Correa-Bautista JE, Ramírez-Vélez R. 2019. Gait speed as a mediator of the effect of sarcopenia on dependency in activities of daily living. Journal of Cachexia, Sarcopeina and Muscle 10(5):1009-1015
Perna S, Guido D, Grassi M, Rondanelli M. 2015. Association between muscle mass and adipo-metabolic profile: a cross-sectional study in older subjects. Clinical Interventions in Aging 2015(10):499-504
Phielix E, Mensink M. 2008. Type 2 diabetes mellitus and skeletal muscle metabolic function. Physiology & Behavior 94(2):252-258
Polterauer S, Grimm C, Hofstetter G, Concin N, Natter C, Sturdza A, Pötter R, Marth C, Reinthaller A, Heinze G. 2012. Nomogram prediction for overall survival of patients diagnosed with cervical cancer. British Journal of Cancer 107(6):918-924
Rafael K, Archdeacon MT. 2016. Surgical management of patellar fractures. The Orthopedic Clinics of North America 47(1):77-83
Rees S, Tutton E, Achten J, Bruce J, Costa ML. 2019. Patient experience of long-term recovery after open fracture of the lower limb: a qualitative study using interviews in a community setting. BMJ Open 9(10):e031261
Ring D, Jupiter JB. 2004. Operative release of ankylosis of the elbow due to heterotopic ossification. Surgical technique. The Journal of Bone and Joint Surgery American 86-A(Suppl 1):2-10
Rondanelli M, Talluri J, Peroni G, Donelli C, Guerriero F, Ferrini K, Riggi E, Sauta E, Perna S, Guido D. 2017. Beyond body mass index. Is the Body Cell Mass Index (BCMI) a useful prognostic factor to describe nutritional, inflammation and muscle mass status in hospitalized elderly? Body cell mass Index links in elderly. Clinical Nutrition 2017:30112-30117
Sauerbrei W, Royston P, Binder H. 2007. Selection of important variables and determination of functional form for continuous predictors in multivariable model building. Statistics in Medicine 26(30):5512-5528
Stone E, Skubic M, Rantz M, Abbott C, Miller S. 2015. Average in-home gait speed: investigation of a new metric for mobility and fall risk assessment of elders. Gait & Posture 41(1):57-62
Szulc P, Feyt C, Chapurlat R. 2016. High risk of fall, poor physical function, and low grip strength in men with fracture—the STRAMBO study. Journal of Cachexia, Sarcopenia and Muscle 7(3):299-311
Tan S, Li W, Wang J. 2012. Effects of six months of combined aerobic and resistance training for elderly patients with a long history of type 2 diabetes. Journal of Sports Science & Medicine 11(3):495-501
Trierweiler H, Kisielewicz G, Hoffmann Jonasson T, Rasmussen Petterle R, Aguiar Moreira C, Zeghbi Cochenski Borba V. 2018. Sarcopenia: a chronic complication of type 2 diabetes mellitus. Diabetology & Metabolic Syndrome 10(25):1-9
Van Calster B, Wynants L, Verbeek JFM, Verbakel JY, Christodoulou E, Vickers AJ, Roobol MJ, Steyerberg EW. 2018. Reporting and interpreting decision curve analysis: a guide for investigators. European Urology 74(6):796-804
Veronese N, Stubbs B, Punzi L, Soysal P, Incalzi RA, Saller A, Maggi S. 2019. Effect of nutritional supplementations on physical performance and muscle strength parameters in older people: a systematic review and meta-analysis. Ageing Research Reviews 51:48-54
Vickers AJ, Cronin AM, Elkin EB, Gonen M. 2008. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Medical Informatics and Decision Making 8(1):53
Volpato S, Bianchi L, Cherubini A, Landi F, Maggio M, Savino E, Bandinelli S, Ceda GP, Guralnik JM, Zuliani G, Ferrucci L+1 more. 2014. Prevalence and clinical correlates of sarcopenia in community-dwelling older people: application of the EWGSOP definition and diagnostic algorithm. The Journals of Gerontology Series A, Biological Sciences and Medical Sciences 69(4):438-446
Volpato S1, Bianchi L, Lauretani F, Lauretani F, Bandinelli S, Guralnik JM, Zuliani G, Ferrucci L. 2012. Role of muscle mass and muscle quality in the association between diabetes and gait speed. Diabetes Care 35(8):1672-1679
Von Haehling S, Morley JE, Anker SD. 2010. An overview of sarcopenia: facts and numbers on prevalence and clinical impact. Journal of Cachexia, Sarcopenia and Muscle 1(2):129-133
Wang H, Hai S, Cao L, Zhou J, Liu P, Dong B-RJBg. 2016. Estimation of prevalence of sarcopenia by using a new bioelectrical impedance analysis in Chinese community-dwelling elderly people. BMC Geriatrics 16(1):216
Wang K, Gong M, Xie S, Zhang M, Zheng H, Zhao X, Liu C. 2019. Nomogram prediction for the 3-year risk of type 2 diabetes in healthy mainland China residents. The EPMA Journal 10(3):227-237
Wang W, Jiang SC, Liu S, Ruan HJ, Fan CY. 2014. Stability of severely stiff elbows after complete open release: treatment by ligament repair with suture anchors and hinged external fixator. Journal of Shoulder and Elbow Surgery 23(10):1537-1544
Wang X, Hu Z, Hu J, Du J, Mitch WE. 2006. Insulin resistance accelerates muscle protein degradation: activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology 147(9):4160-4168
Wanigatunga AA, Gill TM, Marsh AP, Hsu FC, Yaghjyan L, Woods AJ, Glynn NW, King AC, Newton Jr RL, Fielding RA, Pahor M, Manini TM, Lifestyles Intervention and Independence for Elders Study Investigators+3 more. 2019. Effect of hospitalizations on physical activity patterns in mobility-limited older adults. Journal of the American Geratrics Society 67(2):261-268
Wei L, Champman S, Li X, Li X, Li S, Chen R, Bo N, Chater A, Horne R. 2017. Beliefs about medicines and non-adherence in patients with stroke, diabetes mellitus and rheumatoid arthritis: a cross-sectional study in China. BMJ Open 7(10):e017293
Yu R, Wong M, Leung J, Lee J, Auyeung TW, Woo J. 2014. Incidence, reversibility, risk factors and the protective effect of high body mass index against sarcopenia in community-dwelling older Chinese adults. Geriatrics & Gerontology International 14:15-28
Zhu L, Jin L, Li S, Chen K, Jia W, Shan Q, Walter S, Song E, Su F. 2013. Which nomogram is best for predicting non-sentinel lymph node metastasis in breast cancer patients? A meta-analysis. Breast Cancer Research and Treatment 137(3):783-795
Yi-sheng Chen1, Yan-xian Cai2, Xue-ran Kang3,4,5, Zi-hui Zhou1, Xin Qi1, Chen-ting Ying1, Yun-peng Zhang1, Jie Tao1
1 Department of Orthopedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2 Department of Plastic Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
3 Department of Otolaryngology-Head and Neck Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
4 Ear Institute, Shanghai JiaoTong University School of Medicine, Shanghai, China
5 Shanghai Key Laboratory of Translational Medicine on Ear and Nose diseases, Shanghai, China
© 2020 Chen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.